Current Status of Dyslipidemia Treatment for Stroke Prevention

Elizabeth Aradine; Yan Hou; Carolyn A. Cronin; Seemant Chaturvedi

doi:10.1007/s11910-020-01052-4

Current Status of Dyslipidemia Treatment for Stroke Prevention

Elizabeth Aradine, Yan Hou, Carolyn A. Cronin, Seemant Chaturvedi

Research output: Contribution to journal › Review article › peer-review

Abstract

Purpose of Review: Elevated cholesterol is an established risk factor for ischemic stroke. The value of statins for stroke prevention has been clear for more than a decade. Recent Findings: However, the use of new medication combinations such as ezetimibe or proprotein convertase subtilisin–kexin type 9 inhibitors plus statins is increasing and the value for reducing stroke has been shown for these combination therapies. Recent data also support the strategy of lowering triglycerides for stroke prevention. Summary: A modern approach to dyslipidemia treatment and its relation to stroke prevention is summarized in this paper.

Original language	English (US)
Article number	31
Journal	Current neurology and neuroscience reports
Volume	20
Issue number	8
DOIs	https://doi.org/10.1007/s11910-020-01052-4
State	Published - Aug 1 2020
Externally published	Yes

Keywords

Cholesterol
Low-density lipoprotein
Statins
Stroke
Triglycerides

ASJC Scopus subject areas

Neuroscience(all)
Clinical Neurology

Access to Document

10.1007/s11910-020-01052-4

Fingerprint Dive into the research topics of 'Current Status of Dyslipidemia Treatment for Stroke Prevention'. Together they form a unique fingerprint.

Cite this

@article{39e2e1821808458093d7d6ba5cf9825e,

title = "Current Status of Dyslipidemia Treatment for Stroke Prevention",

abstract = "Purpose of Review: Elevated cholesterol is an established risk factor for ischemic stroke. The value of statins for stroke prevention has been clear for more than a decade. Recent Findings: However, the use of new medication combinations such as ezetimibe or proprotein convertase subtilisin–kexin type 9 inhibitors plus statins is increasing and the value for reducing stroke has been shown for these combination therapies. Recent data also support the strategy of lowering triglycerides for stroke prevention. Summary: A modern approach to dyslipidemia treatment and its relation to stroke prevention is summarized in this paper.",

keywords = "Cholesterol, Low-density lipoprotein, Statins, Stroke, Triglycerides",

author = "Elizabeth Aradine and Yan Hou and Cronin, {Carolyn A.} and Seemant Chaturvedi",

year = "2020",

month = aug,

day = "1",

doi = "10.1007/s11910-020-01052-4",

language = "English (US)",

volume = "20",

journal = "Current Neurology and Neuroscience Reports",

issn = "1528-4042",

publisher = "Current Medicine Group",

number = "8",

}

TY - JOUR

T1 - Current Status of Dyslipidemia Treatment for Stroke Prevention

AU - Aradine, Elizabeth

AU - Hou, Yan

AU - Cronin, Carolyn A.

AU - Chaturvedi, Seemant

PY - 2020/8/1

Y1 - 2020/8/1

N2 - Purpose of Review: Elevated cholesterol is an established risk factor for ischemic stroke. The value of statins for stroke prevention has been clear for more than a decade. Recent Findings: However, the use of new medication combinations such as ezetimibe or proprotein convertase subtilisin–kexin type 9 inhibitors plus statins is increasing and the value for reducing stroke has been shown for these combination therapies. Recent data also support the strategy of lowering triglycerides for stroke prevention. Summary: A modern approach to dyslipidemia treatment and its relation to stroke prevention is summarized in this paper.

AB - Purpose of Review: Elevated cholesterol is an established risk factor for ischemic stroke. The value of statins for stroke prevention has been clear for more than a decade. Recent Findings: However, the use of new medication combinations such as ezetimibe or proprotein convertase subtilisin–kexin type 9 inhibitors plus statins is increasing and the value for reducing stroke has been shown for these combination therapies. Recent data also support the strategy of lowering triglycerides for stroke prevention. Summary: A modern approach to dyslipidemia treatment and its relation to stroke prevention is summarized in this paper.

KW - Cholesterol

KW - Low-density lipoprotein

KW - Statins

KW - Stroke

KW - Triglycerides

UR - http://www.scopus.com/inward/record.url?scp=85086716908&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85086716908&partnerID=8YFLogxK

U2 - 10.1007/s11910-020-01052-4

DO - 10.1007/s11910-020-01052-4

M3 - Review article

C2 - 32572590

AN - SCOPUS:85086716908

VL - 20

JO - Current Neurology and Neuroscience Reports

JF - Current Neurology and Neuroscience Reports

SN - 1528-4042

IS - 8

M1 - 31

ER -

Current Status of Dyslipidemia Treatment for Stroke Prevention

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this